AMERICAN GENE TECHNOLOGIES INTERNATIONAL
American Gene Technologies (AGT) is focused on creating long-term value for patients, society, investors and donors by developing and testing cutting-edge gene therapies to cure some of humanity’s worst diseases. AGT’s HIV cure clinical trial could not only lead to a blockbuster drug that brings relief to one of society's most elusive epidemics, but it could prove the efficiency and effectiveness of AGT’s platform technologies to cure dozens of diseases ranging from viruses to cancers.
AMERICAN GENE TECHNOLOGIES INTERNATIONAL
Industry:
Biotechnology Genetics Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.americangene.com
Total Employee:
11+
Status:
Active
Contact:
301-337-2100
Email Addresses:
[email protected]
Total Funding:
30.2 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Font Awesome Global Site Tag
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Current Employees Featured
Founder
Investors List
ROC VENTURE GROUP
ROC VENTURE GROUP investment in Series F - American Gene Technologies International
Alumni Ventures
Alumni Ventures investment in Series D - American Gene Technologies International
Vye Ventures
Vye Ventures investment in Series D - American Gene Technologies International
Ride Wave Ventures
Ride Wave Ventures investment in Series D - American Gene Technologies International
Gaingels
Gaingels investment in Series D - American Gene Technologies International
10X Capital
10X Capital investment in Series D - American Gene Technologies International
National Institutes of Health
National Institutes of Health investment in Series C - American Gene Technologies International
Odeon Capital Partners
Odeon Capital Partners investment in Series C - American Gene Technologies International
Alumni Ventures
Alumni Ventures investment in Series C - American Gene Technologies International
Gaingels
Gaingels investment in Series C - American Gene Technologies International
Official Site Inspections
http://www.americangene.com Semrush global rank: 2.82 M Semrush visits lastest month: 5.95 K
Unable to get host informations!!!
More informations about "American Gene Technologies International"
Leveraging the Power of Gene Therapy to Reduce …
AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.See details»
American Gene Technologies International - Crunchbase
Contact Email [email protected] Phone Number 301-337-2100 American Gene Technologies (AGT) is focused on creating long-term value for patients, society, investors and …See details»
American Gene Technologies® International Inc. Information
*** See our extensive award winning patents on our website *** HIV/AIDS Immunotherapy for HIV disease with gene-modified T cells IMMUNO-ONCOLOGY Activates innate T cell immunity …See details»
Our Corporate Profile: Cell and Gene Therapy for Possible Cures ...
American Gene Technologies is followed by the analyst listed above. Please note that any opinions, estimates or forecasts regarding American Gene Technologies performance made …See details»
American Gene - Company Profile - Tracxn
Aug 17, 2021 American Gene - Developer of lentivirus therapies for the treatment of cancer and other chronic human diseases. Raised a total funding of $52.8M over 5 rounds from 4 …See details»
American Gene Technologies - PitchBook
American Gene Technologies General Information Description. Developer of proprietary gene-delivery of rapid development of cell and gene therapies designed to cure infectious diseases, cancers, and inherited disorders.See details»
americangene.com - Whois.com
Dec 3, 2011 Whois Lookup for americangene.com. Login Sign up My Account Logout; Domains. Registration ... Registration Private Tech Organization: Domains By Proxy, LLC Tech Street: …See details»
American Gene Technologies (USA) Funding: $30.2M - Medical …
AGT uses a proprietary gene delivery platform to rapidly develop patented gene and cell therapies that cure infectious disease, monogenic disorders, and cancers by targeting their genetic root...See details»
AMERICAN GENE TECHNOLOGIES INTERNATIONAL - VentureRadar
Similar Companies: Precision Biosciences USA Publicly Traded Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and …See details»
Is American Gene Technologies® open to collaborate and …
Our therapeutic platforms are patent-protected intellectual property that enable the rapid development of new gene and cell therapeutic candidates. American Gene Technologies is a …See details»
LEADERSHIP TEAM - American Gene Technologies
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of...See details»
American Gene Technologies International - ZoomInfo
Oct 18, 2021 American Gene Technologies International contact info: Phone number: (301) 337-2100 Website: www.americangene.com What does American Gene Technologies …See details»
How does it work? - knowledgebase.americangene.com
Gene and cell therapies do not work in the same way as traditional drugs. AGT103-T is made by taking a patient's white blood cells, giving them a specialized anti-HIV gene, and then giving …See details»
FDA Approves American Gene Technologies (AGT) to Move …
ROCKVILLE, Md., Aug. 11, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announced today approval by the FDA (Food and Drug Administration) to begin Phase 1, the …See details»
What is the current status of American Gene Technologies® Phase …
What is the current status of American Gene Technologies® Phase 1 HIV clinical trial? American Gene Technologies has officially completed its Phase 1 clinical trial for AGT103-T and …See details»
Our Technology: Innovation in Immuno-Oncology | AGT
American Gene Technologies ® is creating the foundation for a fundamentally new approach to medicine with a gene therapy “cure platform” that harnesses the power of lentivirus vectors to …See details»
Epigenetics, Health, and Disease | Genomics and Your Health | CDC
Nov 13, 2024 Epigenetics and exposures. Your epigenetics can change in response to your behaviors and environment. Nutrition during pregnancy. A pregnant person's environment and …See details»
When will results from the Phase 1 HIV clinical trial be released …
We cannot definitively say when results will be released, but we hope to share some data by the end of December 2022. Please visit our site for updates.See details»
The History of Our Gene Therapy Company - American Gene …
The independent Data Safety and Monitoring Board (DSMB) overseeing the trial of American Gene Technologies’ HIV gene therapy found no serious adverse events (SAEs) from the …See details»
Dr. Jeff Boyle Appointed as Chief Science Officer for American …
Jun 21, 2022 Most recently, Dr. Boyle was president of Ellume USA LLC. He built Ellume’s U.S. organization from the ground up, constructing and commissioning an automated …See details»